Disseminating PCOR findings to Reduce Racial Disparities in Surgical Sterilization
传播 PCOR 研究结果以减少绝育手术中的种族差异
基本信息
- 批准号:10650016
- 负责人:
- 金额:$ 50万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Abstract:
This proposal, submitted in response to RFA-HS-22-001, in the priority area of “improving maternal health,” is
prompted by long-standing racial and ethnic disparities in use of permanent contraception (historically called
“surgical sterilization”). In the US, permanent contraceptive procedures are most commonly performed on
women of color, women with chronic conditions such as diabetes, and those residing in rural communities.
Although permanent contraception aligns well with some patients’ reproductive life plans, reports that 10% of
women regret having undergone these procedures are troubling. These regrets and racial disparities are
especially problematic given recent PCOR demonstrating that long-acting reversible contraceptives, such as
hormonal IUDs are both more effective and less likely to cause pelvic pain than permanent contraceptive
procedures. To disseminate PCOR about the comparative safety and real-world effectiveness of alternatives to
permanent contraception, we will adapt the advance care planning (ACP) framework, which has been used to
ensure that patients receive medical care when approaching their end of life that aligns with their personal
treatment goals. This paradigm is a critical tool for supporting patients in making complex medical decisions,
by emphasizing elicitation of values, communication skill building, and shared decision-making. By preparing
patients approaching the end of their reproductive life to more effectively communicate to clinicians their
personal values, priorities, and treatment goals, we will adapt the ACP model for reproductive life planning
(RLP), with input from patients (Aim 1, focus groups) and clinicians (Aim 2, semi-structured interviews). We will
then conduct an individual-level randomized clinical trial comparing this approach to disseminating PCOR
relevant to discussions of permanent contraception with 300 women who identify as Black or have a chronic
condition such as diabetes, and who wish to avoid future pregnancy (Aim 3). In evaluating this intervention, our
experienced multi-disciplinary team will carefully examine patient-reported outcomes related to communication
and satisfaction with care. We will also rigorously analyze heterogeneity of treatment effects by clinical and
patient-level contextual factors to inform the potential need for future refinement of this ACP-RLP paradigm. By
increasing equitable access to alternatives to permanent contraception, this project strives to increase the
proportion of US women who are using a method of contraception that aligns with their personal preferences
and reduce the proportion of individuals who regret having undergone a permanent contraceptive procedure.
摘要:
这项提案是根据RFA-HS-22-001,在“改善产妇健康”这一优先领域提出的,
由于在使用永久避孕措施方面长期存在的种族和民族差异(历史上称为
“外科绝育”)。在美国,永久避孕程序最常见的是在
有色人种妇女、患有糖尿病等慢性病的妇女以及居住在农村社区的妇女。
尽管永久避孕措施与一些患者的生殖生活计划很好地吻合,但报告称,10%的
女性后悔接受了这些手术是令人担忧的。这些遗憾和种族差距是
尤其是考虑到最近的PCOR表明,长效可逆避孕药,如
激素性宫内节育器比永久性避孕药更有效,而且不太可能导致盆腔疼痛
程序。传播PCOR关于替代品的相对安全性和实际有效性的信息
为了实现永久避孕,我们将调整预先护理计划(ACP)框架,该框架已被用于
确保患者在生命接近尾声时得到与其个人相一致的医疗护理
治疗目标。这一范例是支持患者做出复杂医疗决定的关键工具,
通过强调价值观的启发、沟通技能的培养和共同决策。通过准备
即将结束生殖生命的患者,以便更有效地与临床医生沟通
根据个人价值观、优先事项和治疗目标,我们将调整ACP模式以进行生殖生活规划
(RLP),患者(目标1,焦点小组)和临床医生(目标2,半结构化访谈)的意见。我们会
然后进行个人水平的随机临床试验,比较这种方法在传播PCOR方面的作用
与300名自认为是黑人或患有慢性病的妇女讨论永久避孕有关
糖尿病等疾病,以及希望避免未来怀孕的妇女(目标3)。在评估这一干预措施时,我们
经验丰富的多学科团队将仔细检查患者报告的与沟通相关的结果
对护理的满足感。我们还将严格分析治疗效果的异质性,通过临床和
患者水平的背景因素,以告知未来对这一ACP-RLP范例进行改进的潜在需要。通过
为了增加获得永久避孕替代办法的公平机会,该项目努力增加
使用符合个人喜好的避孕方法的美国女性比例
并减少后悔接受了永久性避孕程序的个人比例。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELEANOR Bimla SCHWARZ其他文献
ELEANOR Bimla SCHWARZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELEANOR Bimla SCHWARZ', 18)}}的其他基金
Harnessing Health IT to Prevent Medication-Induced Birth Defects
利用健康信息技术预防药物引起的出生缺陷
- 批准号:
7493505 - 财政年份:2007
- 资助金额:
$ 50万 - 项目类别:
Harnessing Health IT to Prevent Medication-Induced Birth Defects
利用健康信息技术预防药物引起的出生缺陷
- 批准号:
7688031 - 财政年份:2007
- 资助金额:
$ 50万 - 项目类别:
Harnessing Health IT to Prevent Medication-Induced Birth Defects
利用健康信息技术预防药物引起的出生缺陷
- 批准号:
7359394 - 财政年份:2007
- 资助金额:
$ 50万 - 项目类别:
Contraceptive Services/Primary Care to Prevent Birth Defects
预防出生缺陷的避孕服务/初级保健
- 批准号:
7932196 - 财政年份:2006
- 资助金额:
$ 50万 - 项目类别:
Contraceptive Services/Primary Care Prevent Birth Defect
避孕服务/初级保健预防出生缺陷
- 批准号:
7014153 - 财政年份:2006
- 资助金额:
$ 50万 - 项目类别:
Contraceptive Services/Primary Care to Prevent Birth Defects
预防出生缺陷的避孕服务/初级保健
- 批准号:
7454490 - 财政年份:2006
- 资助金额:
$ 50万 - 项目类别:
Contraceptive Services/Primary Care to Prevent Birth Defects
预防出生缺陷的避孕服务/初级保健
- 批准号:
7665135 - 财政年份:2006
- 资助金额:
$ 50万 - 项目类别:
相似海外基金
Clinical Decision Support for Disseminating and Implementing Patient-Centered Outcomes Research (PCOR) Clinical Evidence
用于传播和实施以患者为中心的结果研究 (PCOR) 临床证据的临床决策支持
- 批准号:
10553545 - 财政年份:2022
- 资助金额:
$ 50万 - 项目类别:
NCATS LINKAGE HONEST BROKER (LHB) - PATIENT-CENTERED OUTCOMES RESEARCH (PCOR) TRUST FUND ASPE NATIONAL COVID-19 LONGITUDINAL RESEARCH DATABASE LINKED
NCATS 链接诚实经纪人 (LHB) - 以患者为中心的结果研究 (PCOR) 信托基金 ASPE 国家 COVID-19 纵向研究数据库链接
- 批准号:
10722511 - 财政年份:2022
- 资助金额:
$ 50万 - 项目类别:
Clinical Decision Support for Disseminating and Implementing Patient-Centered Outcomes Research (PCOR) Clinical Evidence
用于传播和实施以患者为中心的结果研究 (PCOR) 临床证据的临床决策支持
- 批准号:
10706516 - 财政年份:2022
- 资助金额:
$ 50万 - 项目类别:
Screening and Management of Unhealthy Alcohol Use in Primary Care: Dissemination and Implementation of PCOR Evidence
初级保健中不健康饮酒的筛查和管理:PCOR 证据的传播和实施
- 批准号:
10259712 - 财政年份:2019
- 资助金额:
$ 50万 - 项目类别:
Restoring Primary Care in Virginia: PCOR Learning as a Pathway to Value
恢复弗吉尼亚州的初级保健:PCOR 学习是实现价值的途径
- 批准号:
9057968 - 财政年份:2015
- 资助金额:
$ 50万 - 项目类别:
Understanding Health Care Delivery Systems PCOR Adoption and System Performance
了解医疗保健服务系统 PCOR 采用和系统性能
- 批准号:
8954103 - 财政年份:2015
- 资助金额:
$ 50万 - 项目类别:
Disseminating and Implementing PCOR through the Oklahoma Primary Healthcare Extension System
通过俄克拉荷马州初级医疗保健扩展系统传播和实施 PCOR
- 批准号:
9276272 - 财政年份:2015
- 资助金额:
$ 50万 - 项目类别:
Restoring Primary Care in Virginia: PCOR Learning as a Pathway to Value
恢复弗吉尼亚州的初级保健:PCOR 学习是实现价值的途径
- 批准号:
8884960 - 财政年份:2015
- 资助金额:
$ 50万 - 项目类别:
Understanding Health Care Delivery Systems PCOR Adoption and System Performance
了解医疗保健服务系统 PCOR 采用和系统性能
- 批准号:
9340121 - 财政年份:2015
- 资助金额:
$ 50万 - 项目类别:
The University of Washington Patient Centered Outcomes Research Partnership (PCOR
华盛顿大学以患者为中心的成果研究合作伙伴 (PCOR
- 批准号:
9294936 - 财政年份:2014
- 资助金额:
$ 50万 - 项目类别: